U.S. Akoya Biosciences, Boston Beer Company, Victory Capital Holdings
May 14 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Akoya Biosciences, Boston Beer Company and Victory Capital Holdings on Tuesday.
HIGHLIGHTS
* Akoya Biosciences Inc AKYA.O: Canaccord Genuity cuts target price to $6 from $10 |
* Boston Beer Company Inc SAM.N: Jefferies raises target price to $360 from $335 |
* Fortrea Holdings Inc FTRE.O: Evercore ISI cuts target price to $31 from $43 |
* Medical Properties Trust Inc MPW.N: RBC cuts to sector perform from outperform |
* Victory Capital Holdings Inc VCTR.O: RBC raises target price to $56 from $47 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* AAR Corp AIR.N: Stifel raises target price to $86 from $81 |
* Acrivon Therapeutics Inc ACRV.O: H.C. Wainwright raises target price to $22 from $20 |
* Actinium Pharmaceuticals Inc ATNM.A: Stephens initiates coverage with overweight rating |
* Actinium Pharmaceuticals Inc ATNM.A: Stephens initiates coverage with price target $25 |
* Advanced Micro Devices Inc AMD.O: Evercore ISI cuts target price to $193 from $200 |
* Agilon Health Inc AGL.N: Jefferies cuts target price to $5.75 from $6.5 |
* Agilysys Inc AGYS.O: Northland Capital raises target price to $118 from $105 |
* Agilysys Inc AGYS.O: Oppenheimer raises target price to $100 from $95 |
* Airsculpt Technologies Inc AIRS.O: Leerink Partners cuts target price to $5.00 from $8.25 |
* Airsculpt Technologies Inc AIRS.O: Leerink Partners cuts to market perform from outperform |
* Akoya Biosciences Inc AKYA.O: BTIG cuts target price to $6 from $9 |
* Akoya Biosciences Inc AKYA.O: Canaccord Genuity cuts target price to $6 from $10 |
* Akoya Biosciences Inc AKYA.O: JP Morgan cuts target price to $7 from $10 |
* Allogene Therapeutics Inc ALLO.O: B. Riley cuts target price to $7 from $10 |
* Allogene Therapeutics Inc ALLO.O: Stifel raises target price to $4.6 from $4.4 |
* Alta Equipment Group Inc ALTG.N: Raymond James cuts target price to $14 from $19.5 |
* Ameresco Inc AMRC.N: UBS raises target price to $39 from $36 |
* American Eagle Outfitters Inc AEO.N: TD Cowen raises target price to $25 from $23 |
* American Electric Power Company Inc AEP.O: BMO raises target price to $99 from $95 |
* Amicus Therapeutics Inc FOLD.O: Guggenheim raises to buy from neutral |
* Amylyx Pharmaceuticals Inc AMLX.O: Mizuho cuts target price to $3 from $4 |
* Angel Oak Mortgage REIT Inc AOMR.N: UBS raises target price to $10.5 from $10 |
* Antero Resources Corp AR.N: BMO raises target price to $35 from $30 |
* APA Corporation APA.O: BMO cuts target price to $35 from $40 |
* Applied DNA Sciences Inc APDN.O: Maxim Group cuts to hold from buy |
* Arcellx Inc ACLX.O: Evercore ISI initiates coverage with outperform rating; PT $85 |
* Aris Water Solutions Inc ARIS.N: Evercore ISI raises target price to $20 from $16 |
* Atlanticus Holdings Corp ATLC.O: Jefferies cuts target price to $40 from $50 |
* Atmos Energy ATO.N: Barclays raises target price to $129 from $121 |
* Atmos Energy ATO.N: Wells Fargo raises target price to $132 from $130 |
* Atmos Energy ATO.N: Wells Fargo raises to overweight from equal-weight |
* Avalonbay Communities Inc AVB.N: Scotiabank raises target price to $213 from $193 |
* Avalonbay Communities Inc AVB.N: UBS raises target price to $210 from $199 |
* Baker Hughes Co BKR.O: BMO cuts target price to $38 from $40 |
* Baldwin Insurance Group Inc BRP.O: UBS raises target price to $37 from $35 |
* Banc of California Inc BANC.N: Stephens cuts target price to $15 from $16 |
* Berry Corporation (Bry) BRY.O: BMO cuts target price to $8 from $9 |
* Biomarin Pharmaceutical BMRN.O: Evercore ISI initiates with outperform rating; PT $113 |
* Blue Owl Capital Corp OBDC.N: KBW cuts to market perform from outperform |
* Blue Owl Capital Inc OWL.N: Citigroup resumes coverage with buy rating; target price $21 |
* Blueprint Medicines Corp BPMC.O: Stephens initiates coverage with overweight rating; price target $140 |
* Booz Allen Hamilton Holding Corp BAH.N: Jefferies raises target price to $180 from $170 |
* Boston Beer Company Inc SAM.N: Jefferies raises target price to $360 from $335 |
* Boston Beer Company Inc SAM.N: Jefferies raises to buy from hold |
* Bridgebio Pharma BBIO.O: Evercore ISI initiates coverage with outperform rating; PT $50 |
* Brighthouse Financial Inc BHF.O: KBW cuts target price to $48 from $50 |
* Broadstone Net Lease Inc BNL.N: Truist Securities cuts target price to $16 from $17 |
* Camden Property Trust CPT.N: Scotiabank raises target price to $108 from $104 |
* Camden Property Trust CPT.N: UBS raises target price to $109 from $105 |
* Caredx Inc CDNA.O: Raymond James cuts to market perform from outperform |
* Caretrust REIT Inc CTRE.N: Jefferies raises target price to $28 from $27 |
* Carnival Corp CCL.N: UBS raises target price to $21 from $20 |
* Celanese Corp CE.N: BMO raises target price to $158 from $153 |
* Centuri Holdings CTRI.N: Siebert Williams initiates coverage with buy rating; PT $32 |
* Century Therapeutics Inc IPSC.O: Guggenheim cuts target price to $12 from $14 |
* Chesapeake Energy Corp CHK.O: BMO raises target price to $95 from $93 |
* Chesapeake Utilities Corp CPK.N: RBC raises target price to $125 from $124 |
* Chevron Corp CVX.N: BMO raises target price to $175 from $170 |
* Chuy's Holdings Inc CHUY.O: Stifel cuts target price to $32 from $36 |
* Civista Bancshares Inc CIVB.O: D.A. Davidson cuts target price by $4 to $17 |
* Clearway Energy Inc CWENa.N: Evercore ISI raises target price to $30 from $25 |
* Clearway Energy Inc CWENa.N: RBC raises target price to $26 from $25 |
* Clearway Energy Inc CWENa.N: UBS raises target price to $33 from $32 |
* CMS Energy Corp CMS.N: BMO raises target price to $71 from $68 |
* CNX Resources Corp CNX.N: BMO cuts target price to $24 from $25 |
* Compass Inc COMP.N: Deutsche Bank raises target price to $4 from $3.8 |
* Compass Inc COMP.N: UBS raises target price to $4 from $3.5 |
* Compass Therapeutics Inc. CMPX.O: Jefferies cuts target price to $7 from $8 |
* Compass Therapeutics Inc. CMPX.O: Leerink Partners cuts target price to $10 from $11 |
* Conocophillips COP.N: BMO cuts target price to $135 from $140 |
* Conocophillips COP.N: RBC raises target price to $140 from $135 |
* Constellation Brands Inc STZ.N: Jefferies cuts target price to $311 from $314 |
* Constellation Energy Corp CEG.O: RBC raises target price to $218 from $211 |
* CubeSmart CUBE.N: Truist Securities cuts target price to $44 from $46 |
* Cummins Inc CMI.N: Bernstein raises target price to $321 from $297 |
* CVR Energy Inc CVI.N: UBS cuts target price to $33.75 from $37 |
* Definitive Healthcare Corp DH.O: Jefferies cuts target price to $10 from $12 |
* Delcath Systems Inc DCTH.O: Stephens initiates coverage with overweight rating; price target $25 |
* Deluxe Corp DLX.N: TD Cowen raises target price to $35 from $33 |
* Diamondback Energy Inc FANG.O: BMO cuts target price to $210 from $213 |
* Dril-Quip Inc DRQ.N: Barclays cuts target price to $21 from $22 |
* Edison International EIX.N: Wells Fargo raises target price to $86 from $72 |
* Edison International EIX.N: Wells Fargo raises to overweight from equal-weight |
* Edwards Lifesciences Corp EW.N: Deutsche Bank raises target price to $103 from $86 |
* Edwards Lifesciences Corp EW.N: Deutsche Bank raises to buy from hold |
* Elevation Oncology Inc ELEV.O: Stephens initiates with overweight rating; PT $8 |
* Emerson EMR.N: Berenberg raises target price to $133 from $130 |
* Enhabit Inc EHAB.N: Leerink Partners raises to market perform from underperform |
* EOG Resources Inc EOG.N: BMO cuts target price to $140 from $145 |
* Epam Systems Inc EPAM.N: Mizuho cuts target price to $258 from $345 |
* EPR Properties EPR.N: Truist Securities cuts target price to $44 from $46 |
* Equity Residential EQR.N: Scotiabank raises target price to $72 from $65 |
* Equity Residential EQR.N: UBS raises target price to $75 from $73 |
* Essex Property Trust Inc ESS.N: Scotiabank raises target price to $283 from $256 |
* Essex Property Trust Inc ESS.N: UBS raises target price to $261 from $250 |
* Evergy Inc EVRG.O: Barclays raises target price to $61 from $56 |
* Evolent Health Inc EVH.N: Truist Securities cuts target price to $28 from $34 |
* Exelixis Inc EXEL.O: Stephens initiates coverage with equal-weight rating; PT $23 |
* Expro Group Holdings NV XPRO.N: Barclays raises to overweight from equal-weight; raises PT to $27 from $18 |
* Five Below Inc FIVE.O: Jefferies cuts target price to $200 from $215 |
* Fluence Energy Inc FLNC.O: RBC cuts target price to $29 from $33 |
* Fortrea Holdings Inc FTRE.O: Evercore ISI cuts target price to $31 from $43 |
* Freeport-Mcmoran Inc FCX.N: UBS raises target price to $54 from $41 |
* Fulcrum Therapeutics Inc FULC.O: Leerink Partners raises target price to $16 from $14 |
* Fulcrum Therapeutics Inc FULC.O: Oppenheimer cuts target price to $14 from $16 |
* Gap Inc GPS.N: TD Cowen raises target price to $24 from $21 |
* Global Net Lease Inc GNL.N: Truist Securities raises target price to $8 from $7 |
* Green Plains Inc GPRE.O: Jefferies cuts target price to $37 from $45 |
* Hess Corp HES.N: BMO raises target price to $175 from $165 |
* HF Sinclair Corp DINO.N: BMO cuts target price to $70 from $77 |
* Houlihan Lokey Inc HLI.N: UBS cuts target price to $145 from $157 |
* Hudson Pacific Properties Inc HPP.N: Jefferies cuts target price to $8 from $10 |
* IAC Inc IAC.O: Wells Fargo raises target price to $84 from $82 |
* Inotiv Inc NOTV.O: Jefferies cuts target price to $3.75 from $11.5 |
* Inotiv Inc NOTV.O: Jefferies cuts to hold from buy |
* Inovio Pharmaceuticals Inc INO.O: Stephens initiates coverage with overweight rating; price target $20 |
* Installed Building Products Inc IBP.N: Benchmark raises target price to $270 from $250 |
* Intuit Inc INTU.O: Morgan Stanley raises target price to $740 |
* Iovance Biotherapeutics Inc IOVA.O: Truist Securities cuts PT to $25 from $26 |
* Jackson Financial Inc JXN.N: KBW cuts to market perform from outperform |
* Jackson Financial Inc JXN.N: KBW raises target price to $80 from $75 |
* Jeld-Wen Holding Inc JELD.N: Jefferies cuts target price to $16 from $20 |
* KBR Inc KBR.N: UBS raises target price to $77 from $68 |
* Lear Corp LEA.N: BofA Global Research cuts price objective to $205 from $210 |
* Legend Biotech Corp LEGN.O: Jefferies raises target price to $94 from $93 |
* Legend Biotech Corp LEGN.O: RBC raises target price to $86 from $85 |
* Legend Biotech Corporation LEGN.O: H.C. Wainwright cuts target price to $86 from $87 |
* Liberty Media Corp FWONK.O: Rosenblatt Securities raises target price to $89 from $88 |
* Live Oak Bancshares Inc LOB.N: Truist Securities raises target price to $40 from $38 |
* Luxurban Hotels Inc LUXH.O: Jonestrading cuts to hold rating |
* Madison Square Garden Entertainment Corp MSGE.N: Macquarie raises PT to $46 from $45 |
* Magna International Inc MGA.N: BofA Global Research cuts price objective to $65 from $70 |
* Marathon Oil Corp MRO.N: BMO cuts target price to $30 from $32 |
* Marathon Petroleum Corp MPC.N: BMO cuts target price to $215 from $235 |
* Markel Group Inc MKL.N: Citigroup raises target price to $1435 from $1375 |
* Matador Resources Co MTDR.N: BMO cuts target price to $79 from $80 |
* Medical Properties Trust Inc MPW.N: RBC cuts to sector perform from outperform |
* Mid-America Apartment Communities Inc MAA.N: Scotiabank raises target price to $144 from $139 |
* Mid-America Apartment Communities Inc MAA.N: UBS raises PT to $131 from $126 |
* Moderna MRNA.O: Evercore ISI initiates coverage with in line rating; price target $120 |
* Morgan Stanley Direct Lending Fund MSDL.N: Wells Fargo cuts target price to $21 from $22 |
* Murphy Oil Corp MUR.N: BMO cuts target price to $50 from $55 |
* National Health Investors Inc NHI.N: Jefferies raises target price to $63 from $54 |
* Nelnet Inc NNI.N: TD Cowen raises target price to $96 from $90 |
* Neurocrine Biosciences NBIX.O: Evercore ISI initiates with outperform rating; PT $175 |
* Neurogene Inc NGNE.O: Leerink Partners cuts target price to $45 from $46 |
* Neuronetics Inc STIM.O: William Blair raises to outperform rating |
* Nisource Inc NI.N: Barclays raises target price to $31 from $30 |
* Northwest Natural Holding Co NWN.N: RBC cuts target price to $41 from $45 |
* Nov Inc NOV.N: BMO raises target price to $22 from $21 |
* Novabay Pharmaceuticals Inc NBY.A: Ascendiant Capital Markets cuts PT to $1.75 from $2 |
* Nurix Therapeutics Inc NRIX.O: Stephens initiates coverage with overweight rating; price target $20 |
* Nvidia Corp NVDA.O: Wells Fargo raises target price to $1150 from $970 |
* Oceaneering International OII.N: Barclays cuts target price to $21 from $22 |
* Oceaneering International OII.N: Barclays cuts to underweight from equal-weight |
* Opendoor Technologies Inc OPEN.O: UBS cuts target price to $2.75 from $3 |
* Orange County Bancorp Inc OBT.O: Stephens cuts target price to $53 from $56 |
* Orion Group Holdings Inc ORN.N: Craig-Hallum initiates coverage with buy rating and target price $14 |
* Ormat Technologies Inc ORA.N: UBS raises target price to $100 from $95 |
* Ovintiv Inc OVV.N: BMO cuts target price to $61 from $63 |
* Palo Alto Networks Inc PANW.O: Evercore ISI adds stock to its tactical underperform list |
* Palo Alto Networks Inc PANW.O: Evercore ISI cuts target price to $385 from $405 |
* PBF Energy Inc PBF.N: BMO cuts target price to $65 from $69 |
* Peakstone Realty Trust PKST.N: Truist Securities raises target price to $16 from $15 |
* Penske Automotive Group Inc PAG.N: BofA Global Research cuts price objective to $175 from $180 |
* Permian Resources Corp PR.N: BMO cuts target price to $21 from $22 |
* Permian Resources Corp PR.N: RBC raises target price to $20 from $17 |
* Perpetua Resources Corp PPTA.O: H.C. Wainwright raises target price to $13.25 from $10.5 |
* Perspective Therapeutics CATX.A: RBC initiates coverage With Outperform rating; PT $3 |
* Phillips 66 PSX.N: BMO cuts target price to $170 from $185 |
* Plains All American Pipeline LP PAA.O: RBC raises target price to $18 from $17 |
* Planet Fitness Inc PLNT.N: JP Morgan raises target price to $78 from $68 |
* Planet Fitness Inc PLNT.N: JP Morgan raises to overweight from neutral |
* Prime Medicine Inc PRME.O: Guggenheim cuts target price to $18 from $20 |
* Primerica Inc PRI.N: KBW cuts target price to $255 from $260 |
* Public Storage PSA.N: Truist Securities cuts target price to $306 from $315 |
* R1 RCM Inc RCM.O: Deutsche Bank cuts target price to $14 from $15 |
* Regeneron Pharmaceuticals REGN.O: Evercore ISI initiates coverage with outperform rating |
* Regeneron Pharmaceuticals REGN.O: Evercore ISI initiates coverage with PT $1150 |
* Roblox Corp RBLX.N: Roth MKM cuts target price to $35 from $55 |
* Roblox Corp RBLX.N: Roth MKM cuts to neutral from buy |
* Royal Caribbean Cruises Ltd RCL.N: UBS raises target price to $168 from $154 |
* Sarepta Therapeutics Inc SRPT.O: Oppenheimer raises to outperform from perform |
* Sensei Biotherapeutics SNSE.O: Stephens initiates with overweight rating and $5 price target |
* Shimmick Corporation SHIM.O: Craig-Hallum cuts target price to $4 from $10 |
* Shimmick Corporation SHIM.O: Craig-Hallum cuts to hold from buy |
* Sinclair Inc SBGI.O: Deutsche Bank cuts target price to $16 from $17 |
* SLB SLB.N: zephirin Group raises price objective to $59 from $57 |
* Sphere Entertainment Co SPHR.N: Macquarie cuts target price to $38 from $40 |
* Squarespace Inc SQSP.N: Barclays raises target price to $44 from $40 |
* Squarespace Inc SQSP.N: Citigroup raises target price to $53 from $46 |
* Squarespace Inc SQSP.N: Raymond James cuts to market perform from outperform |
* Squarespace Inc SQSP.N: UBS cuts to neutral from buy |
* Squarespace Inc SQSP.N: UBS cuts to neutral from buy |
* Squarespace Inc SQSP.N: UBS raises target price to $44 from $43 |
* Squarespace Inc SQSP.N: UBS raises target price to $44 from $43 |
* Sun Communities Inc SUI.N: Truist Securities cuts target price to $127 from $136 |
* Talos Energy Inc TALO.N: BMO cuts target price to $14 from $15 |
* Taysha Gene Therapies Inc TSHA.O: Jefferies raises target price to $8 from $2 |
* Taysha Gene Therapies Inc TSHA.O: Jefferies raises to buy from hold |
* Terreno Realty Corp TRNO.N: Jefferies raises target price to $89 from $87 |
* Territorial Bancorp Inc TBNK.O: KBW cuts target price to $9.66 from $10 |
* Transdigm Group Inc TDG.N: Deutsche Bank raises target price to $1435 from $1360 |
* Trex Co Inc TREX.N: JP Morgan raises target price to $95 from $93 |
* Trubridge Inc TBRG.O: Deutsche Bank cuts target price to $11 from $12 |
* Tscan Therapeutics Inc. TCRX.O: Barclays raises target price to $14 from $9 |
* UDR Inc UDR.N: Scotiabank raises target price to $42 from $39 |
* Ulta Beauty Inc ULTA.O: Stifel cuts target price to $475 from $565 |
* United Bankshares Inc UBSI.O: Stephens raises target price to $36 from $34 |
* Valero Energy Corp VLO.N: BMO cuts target price to $182 from $205 |
* Verb Technology Company VERB.O: Ascendiant Capital Markets cuts PT to $4.50 from $5 |
* Verrica Pharmaceuticals Inc VRCA.O: H.C. Wainwright raises PT to $14 from $13 |
* Verrica Pharmaceuticals Inc VRCA.O: Jefferies raises target price to $12 from $10 |
* Verrica Pharmaceuticals Inc VRCA.O: Needham raises target price to $16 from $8 |
* Victory Capital Holdings Inc VCTR.O: RBC raises target price to $56 from $47 |
* Vistra Corp VST.N: RBC raises target price to $105 from $95 |
* Vital Energy Inc VTLE.N: BMO cuts target price to $55 from $63 |
* Vital Energy Inc VTLE.N: Citigroup cuts target price to $60 from $70 |
* Vital Energy Inc VTLE.N: Wells Fargo cuts target price to $54 from $57 |
* Vivid Seats Inc SEAT.O: Deutsche Bank cuts target price to $6.5 from $7 |
* Voyager Therapeutics Inc VYGR.O: Wedbush cuts target price to $8 from $10 |
* Weatherford International Plc WFRD.O: Citigroup initiates coverage With Buy rating |
* Weatherford International Plc WFRD.O: Citigroup initiates coverage With target price $155 |
* Western Digital Corp WDC.O: Citigroup initiates coverage with buy rating; PT $90 |
* Xponential Fitness Inc XPOF.N: Guggenheim cuts target price to $18 from $25 |
(Compiled by Bengaluru Newsroom)
</body></html>Související aktiva
Poslední novinky
Zřeknutí se odpovědnosti: Subjekty skupiny XM Group poskytují služby a přístup do naší online obchodní platformy v režimu „execution-only”, což osobám umožní prohlížet a/nebo použít obsah, dostupný zde nebo prostřednictvím webové stránky, který není určený ke změně nebo šíření. Na takový přístup a použití se vždy vztahují: (i) Všeobecné obchodní podmínky; (ii) Upozornění na rizika; a (iii) Úplné zřeknutí se odpovědnosti. Takový obsah je proto poskytovaný pouze jako obecné informace. Mějte především na paměti, že obsah naší online obchodní platformy není ani žádostí, ani nabídkou vstupu do jakýchkoliv transakcí na finančních trzích. Obchodování na jakémkoliv finančním trhu zahrnuje významnou úroveň rizika pro váš kapitál.
Veškerý materiál, zveřejněný na naší online obchodní platformě, je určený pouze pro vzdělávací/informační účely a neobsahuje ani by neměl být považovaný za finanční, investiční, daňové nebo obchodní rady a doporučení, ani záznamy o našich obchodních cenách, nebo nabídku transakce s jakýmikoliv finančními instrumenty, či nevyžádadnou propagaci pro vaši osobu.
Jakýkoliv obsah třetích stran a také obsah, připravený společností XM, jako jsou názory, novinky, výzkum, analýzy, ceny, další informace nebo odkazy na webové stránky třetích stran, které jsou zobrazeny na tomto webu, jsou poskytovány v neupravené verzi jako obecný tržní komentář, a nepředstavují investiční radu. Pokud je jakýkoliv obsah uváděný jako investiční výzkum, musíte si uvědomit a přijmout, že tento obsah nebyl určený a nebyl připravený v souladu se zákonnými požadavky, vytvořenými pro podporu nezávislosti investičního výzkumu, a jako takový by měl být podle příslušných zákonů a předpisu považovaný pouze za marketingovou komunikaci. Ujistěte se, že jste si přečetli a plně rozumíte našemu Oznámení o seznámení se s riziky a investičním výzkumu, který není nezávislý, týkající se výše uvedených informací, a ke kterým lze přejít zde.
